Yuhan's 10 medicines break 10-billion mark in 2007 sales

Published: 2008-01-11 06:56:00

Updated: 2008-01-11 06:56:00

Yuhan Corporation's ten flagship products exceeded 10-billion sales last year, propelled by strong demand in related sectors.

Of these items, Yuhan's new drug Revanex (revaprazan) surpassed a 10 billion mark in less than one year after launching. Revanex is expected to be one of Yuhan's leading items in the future.

The company plans to set foot 20 new medicines within this year.

It...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.